Effect of human leukocyte alpha interferon on cryoglobulinaemic membranoproliferative glomerulonephritis associated with hepatitis C virus infection.
Gilli
P
P
Division of Nephrology, Arcispedale S. Anna, Ferrara, Italy.
Stabellini
N
N
Storari
A
A
Gualandi
G
G
Guerra
G
G
Ghinelli
F
F
D000998:Antiviral Agents / Q000627:therapeutic use*; D001706:Biopsy; D003449:Cryoglobulinemia / Q000150:complications / Q000473:pathology / Q000628:therapy*; D005260:Female; D015432:Glomerulonephritis, Membranoproliferative / Q000150:complications / Q000473:pathology / Q000628:therapy*; D006526:Hepatitis C / Q000150:complications / Q000473:pathology / Q000628:therapy*; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use*; D007668:Kidney / Q000473:pathology; D008875:Middle Aged; D011994:Recombinant Proteins
D000998:Antiviral Agents; D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins